Erin M Rock Selected Research

Erin M Rock Research Topics

Disease

33	Nausea 12/2023 - 02/2008
15	Vomiting 02/2022 - 02/2009
3	Cannabinoid Hyperemesis Syndrome 01/2022 - 01/2020
2	Neoplasms (Cancer) 12/2023 - 08/2014
1	Hyperthermia 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Chronic Disease (Chronic Diseases) 09/2020
1	Tobacco Use Disorder (Nicotine Dependence) 09/2020
1	Anhedonia 09/2020
1	Diarrhea 02/2020
1	Body Weight (Weight, Body) 02/2020
1	Hyperalgesia 11/2018
1	Inflammation (Inflammations) 11/2018
1	Edema (Dropsy) 11/2018
1	Pain (Aches) 11/2018
1	Anxiety Disorders (Anxiety Disorder) 01/2018
1	Shock 07/2017
1	Medically Unexplained Symptoms 01/2016

Drug/Important Bio-Agent (IBA)

18	CannabinoidsIBA 12/2023 - 06/2011
13	Lithium ChlorideIBA 12/2023 - 10/2013
12	CannabidiolIBA 12/2023 - 02/2008
11	cannabidiolic acidIBA 12/2023 - 08/2014
11	AntiemeticsIBA 02/2022 - 06/2011
11	Dronabinol (THC)FDA LinkGeneric 01/2022 - 10/2013
7	EndocannabinoidsIBA 07/2020 - 02/2008
7	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2020 - 10/2013
5	Morphine (MS Contin)FDA LinkGeneric 02/2022 - 01/2016
5	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2019 - 08/2011
4	Naloxone (Narcan)FDA LinkGeneric 02/2022 - 02/2020
4	5-HT1A Serotonin ReceptorIBA 01/2022 - 06/2011
4	SaccharinIBA 09/2020 - 06/2011
4	Monoacylglycerol LipasesIBA 07/2018 - 04/2012
4	Glycerol (Glycerine)FDA LinkGeneric 01/2016 - 04/2012
3	Alanine (L-Alanine)FDA Link 12/2023 - 09/2020
3	AmidesIBA 02/2022 - 09/2020
3	Fatty Acids (Saturated Fatty Acids)IBA 02/2022 - 09/2020
3	EstersIBA 01/2021 - 01/2018
3	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 08/2011
3	RimonabantIBA 11/2018 - 10/2013
3	MJN110IBA 07/2018 - 02/2015
3	Ondansetron (Zofran)FDA LinkGeneric 07/2018 - 08/2014
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2015 - 02/2008
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2022 - 09/2020
2	muskIBA 02/2022 - 06/2015
2	N-oleoylglycineIBA 01/2021 - 02/2020
2	HU-580IBA 09/2020 - 01/2018
2	anandamide (arachidonylethanolamide)IBA 09/2020 - 01/2016
2	MK-886IBA 03/2020 - 10/2015
2	PF 3845IBA 01/2019 - 10/2015
2	GW 7647IBA 01/2019 - 11/2017
2	AutoreceptorsIBA 07/2018 - 08/2011
2	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2018 - 06/2011
2	Aprepitant (Emend)FDA Link 01/2016 - 08/2014
2	AM 251 (AM251)IBA 10/2013 - 04/2012
1	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2022
1	PPAR alphaIBA 03/2020
1	AcidsIBA 03/2020
1	SC 24IBA 02/2020
1	1-pentyl-3-(1-naphthoyl)indoleIBA 01/2020
1	CorticosteroneIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 11/2018
1	CarrageenanIBA 11/2018
1	Transient Receptor Potential ChannelsIBA 11/2018
1	1-(3-chlorophenyl)biguanideIBA 07/2018
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 07/2018
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 07/2018
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2018
1	tetralinIBA 01/2018
1	Serotonin 5-HT1 Receptor AntagonistsIBA 01/2018
1	URB937IBA 11/2017
1	iodopravadoline (AM 630)IBA 09/2016
1	HU 308IBA 09/2016
1	CB2 Cannabinoid ReceptorIBA 09/2016
1	Lipase (Acid Lipase)FDA Link 01/2016
1	MonoglyceridesIBA 01/2016
1	Neurokinin-1 Receptor AntagonistsIBA 08/2014
1	cannabidivarinIBA 10/2013
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2012
1	JZL 184IBA 04/2012
1	Arachidonic Acid (Vitamin F)IBA 04/2012
1	EmeticsIBA 08/2011
1	Cannabinoid Receptor AgonistsIBA 08/2011
1	cannabigerolIBA 06/2011
1	Calcium Gluconate (CBG)IBA 06/2011
1	RolipramIBA 02/2009
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 02/2009
1	Phosphodiesterase 4 InhibitorsIBA 02/2009
1	LithiumIBA 02/2008

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 12/2023 - 02/2008
1	Injections 01/2020
1	Oral Administration 09/2016
1	Therapeutics 04/2016